相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IRF2 contributes to myocardial infarction via regulation of GSDMD induced pyroptosis
Yongxing Li et al.
MOLECULAR MEDICINE REPORTS (2022)
The interplay of autophagy and oxidative stress in the pathogenesis and therapy of retinal degenerative diseases
Kun-Che Chang et al.
CELL AND BIOSCIENCE (2022)
Cell-to-Cell Communications in Alcohol-Associated Liver Disease
Natalia A. Osna et al.
FRONTIERS IN PHYSIOLOGY (2022)
Inflammasomes and Pyroptosis of Liver Cells in Liver Fibrosis
Can Gan et al.
FRONTIERS IN IMMUNOLOGY (2022)
Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation
Shu Song et al.
ACTA PHARMACOLOGICA SINICA (2021)
Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis
Susanne Gaul et al.
JOURNAL OF HEPATOLOGY (2021)
NLRP3 inflammasome inhibitor CY-09 reduces hepatic steatosis in experimental NAFLD mice
Xianfei Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Exercise suppresses NLRP3 inflammasome activation in mice with diet-induced NASH: a plausible role of adropin
Wenqi Yang et al.
LABORATORY INVESTIGATION (2021)
Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosis
Shuai Shao et al.
PHARMACOLOGY & THERAPEUTICS (2021)
A long way to go: caspase inhibitors in clinical use
Shanel Dhani et al.
CELL DEATH & DISEASE (2021)
Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation
Qi Lv et al.
ACTA PHARMACEUTICA SINICA B (2021)
An Epigenetic Insight into NLRP3 Inflammasome Activation in Inflammation-Related Processes
Aroa Baragano Raneros et al.
BIOMEDICINES (2021)
The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases
Ya-Shuo Feng et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
CYP2E1 in Alcoholic and Non-Alcoholic Liver Injury. Roles of ROS, Reactive Intermediates and Lipid Overload
Riina Harjumaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Molecular and cellular mechanisms of liver fibrosis and its regression
Tatiana Kisseleva et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases
David W. Crabb et al.
HEPATOLOGY (2020)
Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease
Amine Majdi et al.
JOURNAL OF HEPATOLOGY (2020)
An Acetylation Switch of the NLRP3 Inflammasome Regulates Aging-Associated Chronic Inflammation and Insulin Resistance
Ming He et al.
CELL METABOLISM (2020)
Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting
Matias A. Avila et al.
GUT (2020)
Targeting Macrophage Histone H3 Modification as a Leishmania Strategy to Dampen the NF-κB/NLRP3-Mediated Inflammatory Response
Herve Lecoeur et al.
CELL REPORTS (2020)
FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation
Jun Jacob Hu et al.
NATURE IMMUNOLOGY (2020)
Therapeutic modulation of inflammasome pathways
Dhruv Chauhan et al.
IMMUNOLOGICAL REVIEWS (2020)
Inflammasome activation and regulation: toward a better understanding of complex mechanisms
Danping Zheng et al.
CELL DISCOVERY (2020)
Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor
Sameer Agarwal et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Alcohol dysregulates miR-148a in hepatocytes through FoxO1, facilitating pyroptosis via TXNIP overexpression
Mi Jeong Heo et al.
GUT (2019)
Thioredoxin-Interacting Protein (TXNIP) Associated NLRP3 Inflammasome Activation in Human Alzheimer's Disease Brain
Lexiao Li et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
MCC950 directly targets the NLRP3 ATP- hydrolysis motif for inflammasome inhibition
Rebecca C. Coll et al.
NATURE CHEMICAL BIOLOGY (2019)
The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
Nathan Kelley et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model
Qiang Sun et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
The diverse roles of DNA methylation in mammalian development and disease
Maxim V. C. Greenberg et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Interleukin-1 Family Cytokines: Keystones in Liver Inflammatory Diseases
Louise Barbier et al.
FRONTIERS IN IMMUNOLOGY (2019)
Pharmacological Inhibitors of the NLRP3 Inflammasome
Ayesha Zahid et al.
FRONTIERS IN IMMUNOLOGY (2019)
Andrographolide impairs alpha-naphthylisothiocyanate-induced cholestatic liver injury in vivo
Lei Wang et al.
JOURNAL OF NATURAL MEDICINES (2019)
Therapeutic Epigenetic Reprogramming of Trained Immunity in Myeloid Cells
R. M. Rodriguez et al.
TRENDS IN IMMUNOLOGY (2019)
Epigenetics of chronic inflammatory diseases
Eleni Stylianou
JOURNAL OF INFLAMMATION RESEARCH (2019)
MiR-22 sustains NLRP3 expression and attenuates H. pylori-induced gastric carcinogenesis
S. Li et al.
ONCOGENE (2018)
ACG Clinical Guideline: Alcoholic Liver Disease
Ashwani K. Singal et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Sirtuin 3-induced macrophage autophagy in regulating NLRP3 inflammasome activation
Penghao Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Upregulation of NLRP3 via STAT3-dependent histone acetylation contributes to painful neuropathy induced by bortezomib
Cui-Cui Liu et al.
EXPERIMENTAL NEUROLOGY (2018)
Targeting the NLRP3 inflammasome in inflammatory diseases
Matthew S. J. Mangan et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
OLT1177, a ß-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
Carlo Marchetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity
Hongbin He et al.
NATURE COMMUNICATIONS (2018)
MicroRNA-495 Ameliorates Cardiac Microvascular Endothelial Cell Injury and Inflammatory Reaction by Suppressing the NLRP3 Inflammasome Signaling Pathway
Tao Zhou et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Inflammasome: A Double-Edged Sword in Liver Diseases
Jingyun Luan et al.
FRONTIERS IN IMMUNOLOGY (2018)
Damage-Associated Molecular Patterns in Inflammatory Diseases
Jong Seong Roh et al.
IMMUNE NETWORK (2018)
Hypermethylation of the Micro-RNA 145 Promoter Is the Key Regulator for NLRP3 Inflammasome-Induced Activation and Plaque Formation
Wei Zhong et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2018)
Epigenetic Networks Regulate the Transcriptional Program in Memory and Terminally Differentiated CD8+ T Cells
Ramon M. Rodriguez et al.
JOURNAL OF IMMUNOLOGY (2017)
Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease
Majid Bahabadi et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2017)
Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis
Hideto Kawaratani et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
DNA demethylation of inflammasome-associated genes is enhanced in patients with cryopyrinassociated periodic syndromes
Roser Vento-Tormo et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
Hua Jiang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Opposing effects of Nrf2 and Nrf2-activating compounds on the NLRP3 inflammasome independent of Nrf2-mediated gene expression
Martha Garstkiewicz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Emerging Role of Epigenetic Mechanisms in Alcohol Addiction
Tiffani D. M. Berkel et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2017)
Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer
L. Wu et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents
Kai Xue et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease
Yan Zhou et al.
MOLECULAR NEURODEGENERATION (2016)
The molecular hallmarks of epigenetic control
C. David Allis et al.
NATURE REVIEWS GENETICS (2016)
ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury
Letteria Minutoli et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Mechanism and Regulation of NLRP3 Inflammasome Activation
Yuan He et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
The Role of IL-1 Family Members and Kupffer Cells in Liver Regeneration
Quanhui Tan et al.
BIOMED RESEARCH INTERNATIONAL (2016)
NLRP3 Activation Was Regulated by DNA Methylation Modification during Mycobacterium tuberculosis Infection
Meili Wei et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Gut-Liver Axis in Alcoholic Liver Disease
Gyongyi Szabo
GASTROENTEROLOGY (2015)
Metabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease
Jan Petrasek et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
Yun-Hee Youm et al.
NATURE MEDICINE (2015)
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Rebecca C. Coll et al.
NATURE MEDICINE (2015)
Epigenetic inactivation of the candidate tumor suppressor gene ASC/TMS1 in human renal cell carcinoma and its role as a potential therapeutic target
Qianling Liu et al.
ONCOTARGET (2015)
The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis
Fernando J. Barreyro et al.
LIVER INTERNATIONAL (2015)
Effects of acute ethanol exposure on anxiety measures and epigenetic modifiers in the extended amygdala of adolescent rats
Amul J. Sakharkar et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
High Mobility Group Box-1 (HMGB1) Participates in the Pathogenesis of Alcoholic Liver Disease (ALD)
Xiaodong Ge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Alcoholic disease: Liver and beyond
Alba Rocco et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Biochemical and Structural Aspects of the ATP-Binding Domain in Inflammasome-forming Human NLRP Proteins
Justin A. MacDonald et al.
IUBMB LIFE (2013)
Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity
Hideki Hara et al.
NATURE IMMUNOLOGY (2013)
Inflammation in Alcoholic Liver Disease
H. Joe Wang et al.
ANNUAL REVIEW OF NUTRITION, VOL 32 (2012)
Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
Loredana Santo et al.
BLOOD (2012)
Alcohol Metabolism
Arthur I. Cederbaum
CLINICS IN LIVER DISEASE (2012)
Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during Apoptosis
Kenichi Shimada et al.
IMMUNITY (2012)
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice
Jan Petrasek et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
A promoter DNA demethylation landscape of human hematopoietic differentiation
Vincenzo Calvanese et al.
NUCLEIC ACIDS RESEARCH (2012)
Endoplasmic Reticulum Stress Modulates Liver Inflammatory Immune Response in the Pathogenesis of Liver Ischemia and Reperfusion Injury
Jun Liu et al.
TRANSPLANTATION (2012)
DNA methylation: a promising landscape for immune system-related diseases
Beatriz Suarez-Alvarez et al.
TRENDS IN GENETICS (2012)
Inflammasome-IL-1 beta signaling mediates ethanol inhibition of hippocampal neurogenesis
Jian Zou et al.
FRONTIERS IN NEUROSCIENCE (2012)
Histone H3 Phosphorylation (Ser10, Ser28) and Phosphoacetylation (K9S10) Are Differentially Associated with Gene Expression in Liver of Rats Treated In Vivo with Acute Ethanol
Taryn T. James et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Romidepsin: a novel histone deacetylase inhibitor for cancer
Erin M. Bertino et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Epigenetic regulation in alcoholic liver disease
Pranoti Mandrekar
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor
Erin M. Bowers et al.
CHEMISTRY & BIOLOGY (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Alcohol and Acetaldehyde in Public Health: From Marvel to Menace
Rui Guo et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2010)
The Interleukin-17 Pathway Is Involved in Human Alcoholic Liver Disease
Arnaud Lemmers et al.
HEPATOLOGY (2009)
Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
Mohamed Lamkanfi et al.
JOURNAL OF CELL BIOLOGY (2009)
Relationship between oxidative stress and hepatic glutathione levels in ethanol-mediated apoptosis of polarized hepatic cells
Benita L. McVicker et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Surrogate alcohols and their metabolites modify histone H3 acetylation: Involvement of histone acetyl transferase and histone deacetylase
Mahua Choudhury et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2008)
Brain chromatin remodeling: A novel mechanism of alcoholism
Subhash C. Pandey et al.
JOURNAL OF NEUROSCIENCE (2008)
Inhibition of DNA methylation by antisense oligonucleotide MG98 as cancer therapy
Robert J. Amato
CLINICAL GENITOURINARY CANCER (2007)
Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic importance in glioblastoma multiforme
Ramon Martinez et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Hypermethylation of ASC/TMS1 is a sputum marker for late-stage lung cancer
Emi Ota Machida et al.
CANCER RESEARCH (2006)
Cryopyrin activates the inflammasome in response to toxins and ATP
S Mariathasan et al.
NATURE (2006)
Alcohol and oxidative liver injury
A Dey et al.
HEPATOLOGY (2006)
Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases
B Brueckner et al.
CANCER RESEARCH (2005)
Pharmacology of 5-Aza-2′-deoxycytidine (decitabine)
RL Momparler
SEMINARS IN HEMATOLOGY (2005)
Immune responses to ethanol metabolites and cytokine profiles differentiate alcoholics with or without liver disease
J Latvala et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Redox modulation of chromatin remodeling:: impact on histone acetylation and deacetylation, NF-κB and pro-inflammatory gene expression
I Rahman et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression
K Balasubramanyam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription
K Balasubramanyam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Inhibition of DNA methylation and reactivation of silenced genes by zebularine
JC Cheng et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Chronic ethanol consumption enhances interleukin-1-mediated signal transduction in rat liver and in cultured hepatocytes
SL Valles et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2003)
The PYRIN-CARD protein ASC is an activating adaptor for caspase-1
SM Srinivasula et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
